Cite
HARVARD Citation
Janku, F. et al. (n.d.). 382 Targeting innate immunity with BXCL701 in combination with pembrolizumab in patients with advanced solid cancers: phase 2 basket study. Journal for immunotherapy of cancer. p. A232. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Janku, F. et al. (n.d.). 382 Targeting innate immunity with BXCL701 in combination with pembrolizumab in patients with advanced solid cancers: phase 2 basket study. Journal for immunotherapy of cancer. p. A232. [Online].